Clinical Trials for Marengo Therapeutics

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Marengo Therapeutics

Clinical Trials (2)

NCT06827613
A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
50 participants
Started: Mar 24, 2025 · Completed: Jan 31, 2028
2 conditions1 sponsor8 locations
NCT05592626
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
365 participants
Started: Jan 4, 2023 · Completed: Oct 31, 2026
12 conditions1 sponsor32 locations